Diagnostic performance of APRI, FIB-4 and Fibroscan for assessment of hepatic fibrosis in chronic hepatitis B patients receiving oral antiviral therapy; 7-year real life data
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 11 - 15 November 2016, vol.64
